Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
ADME Processes in Pharmaceutical Sciences : Dosage, Design, and Pharmacotherapy / / edited by Alan Talevi, Pablo A. Quiroga
| ADME Processes in Pharmaceutical Sciences : Dosage, Design, and Pharmacotherapy / / edited by Alan Talevi, Pablo A. Quiroga |
| Autore | Talevi Alan |
| Edizione | [2nd ed. 2024.] |
| Pubbl/distr/stampa | Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (489 pages) |
| Disciplina | 615.19 |
| Altri autori (Persone) | QuirogaPablo A |
| Soggetto topico |
Pharmaceutical chemistry
Pharmacology Toxicology Pharmacy Drugs - Design Drug Design Drug Therapy Pharmacokinetics Drug-Related Side Effects and Adverse Reactions Technology, Pharmaceutical Pharmaceutics Structure-Based Drug Design |
| ISBN | 3-031-50419-4 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part 1: The basics of ADME processes -- Chapter 1-Introduction. Biopharmaceutics and Pharmacokinetics -- Chapter 2-Drug release -- Chapter 3-Drug Absorption -- Chapter 4-Drug Distribution -- Chapter 5-Drug Metabolism -- Chapter 6-Drug Excretion -- Chapter 7-Drug Delivery Routes -- Chapter 8-Compartmental Pharmacokinetic Models -- Chapter 9-Regulatory Requirements and Applications of Physiologically Based Pharmacokinetic Models -- Chapter 10-Drug Drug and Food Drug Interactions of Pharmacokinetic Nature -- Part 2: Specialized topics -- Chapter 11-Nanocarriers: Delivery Routes -- Chapter 12-Advanced Techniques for Quality Assessment of Nanocarriers -- Chapter 13-Nanomedicines Obtained by Nanoprinting -- Chapter 14-Absorption, Distribution, Metabolism and Excretion of Biopharmaceutical Drug Products -- Chapter 15-In silico and in vitro ADME predictions -- Chapter 16-Relationship Between Pharmacokinetics and Pharmacogenomics and Its Impact on Drug Choice and Dose Regimens -- Chapter 17-The Relationship Between Pharmacogenomics and Pharmacokinetics and Its Impact on Drug Choice and Dosing Regimens in Pediatrics -- Chapter 18-Bioavailability and Bioequivalence studies -- Chapter 19-Drug transporters – Physiological role and Their Impact on Pharmacotherapy -- Chapter 20-Blood Flow Distribution and Membrane Transporters As Determinant Factors Of Tissue Drug Concentration. |
| Record Nr. | UNINA-9910847085703321 |
Talevi Alan
|
||
| Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
ADMET for Medicinal Chemists [[electronic resource] ] : A Practical Guide
| ADMET for Medicinal Chemists [[electronic resource] ] : A Practical Guide |
| Autore | Tsaioun Katya |
| Pubbl/distr/stampa | Hoboken, : Wiley, 2012 |
| Descrizione fisica | 1 online resource (524 p.) |
| Disciplina |
615.19
615/.19 |
| Altri autori (Persone) | KatesSteven A |
| Soggetto topico |
Drug Design
Drug Toxicity Drugs - Testing Drugs --Testing --Juvenile literature Pharmaceutical Preparations - chemistry Pharmacokinetics Metabolic Phenomena Drug Discovery Pharmacological Phenomena Natural Science Disciplines Kinetics Chemicals and Drugs Poisoning Biochemical Phenomena Chemistry, Pharmaceutical Substance-Related Disorders Disciplines and Occupations Investigative Techniques Physiological Phenomena Phenomena and Processes Chemical Phenomena Diseases Pharmacology Analytical, Diagnostic and Therapeutic Techniques and Equipment Biological Science Disciplines Chemistry Pharmaceutical Preparations Health & Biological Sciences Pharmacy, Therapeutics, & Pharmacology |
| ISBN |
1-280-59122-6
9786613621054 0-470-91509-9 0-470-91511-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
ADMET for Medicinal Chemists: A Practical Guide; CONTENTS; Preface; Contributors; 1 Introduction; 1.1 Introduction; 1.2 Voyage Through The Digestive System; 1.2.1 The Mouth; 1.2.2 The Stomach; 1.2.3 The Small Intestine: Duodenum; 1.2.4 The Small and Large Intestine: Jejunum, Ileum, Colon; 1.2.5 Hepatic-Portal Vein; 1.3 The Liver Metabolism; 1.3.1 CYP450 (CYPs); 1.4 The Kidneys; 1.4.1 Active Tubular Secretion; 1.4.2 Passive Tubular Reabsorption; 1.5 Conclusions; References; 2 In Silico ADME/Tox Predictions; 2.1 Introduction; 2.2 Key Computer Methods for ADME/Tox Predictions
2.2.1 Drug Discovery2.2.2 Applying or Not ADME/Tox Predictions, Divided Opinions; 2.2.3 In Silico ADME/Tox Methods and Modeling Approaches; 2.2.4 Physicochemistry, Pharmacokinetics, Drug-Like and Lead-Like Concepts; 2.2.5 Lipophilicity; 2.2.6 pKa; 2.2.7 Transport Proteins; 2.2.8 Plasma Protein Binding; 2.2.9 Metabolism; 2.2.10 Elimination; 2.2.11 Toxicity; 2.3 Preparation of Compound Collections and Computer Programs, Challenging ADME/Tox Predictions and Statistical Methods; 2.3.1 Preparation of Compound Collections and Computer Programs 2.3.2 Preparing a Compound Collection: Materials and Methods2.3.3 Cleaning and Designing the Compound Collection; 2.3.4 Searching for Similarity; 2.3.5 Generating 3D Structures; 2.4 ADME/Tox Predictions within Pharmaceutics Companies; 2.4.1 Actelion Pharmaceuticals Ltd.; 2.4.2 Bayer; 2.4.3 Bristol-Myers Squibb; 2.4.4 Hoffmann-La Roche Ltd.; 2.4.5 Neurogen Corporation; 2.4.6 Novartis; 2.4.7 Schering AG; 2.4.8 Vertex Pharmaceuticals; 2.5 Challenging ADME/Tox Predictions; 2.5.1 Tolcapone; 2.5.2 Factor V Inhibitors; 2.5.3 CRF-1 Receptor Antagonists; 2.6 Statistical Methods 2.6.1 Principal Component Analysis2.6.2 Partial Least Square; 2.6.3 Support Vector Machine; 2.6.4 Decision Trees; 2.6.5 Neural Networks; 2.7 Conclusions; References; 3 Absorption and Physicochemical Properties of the NCE; 3.1. Introduction; 3.2. Physicochemical Properties; 3.3. Stability; 3.4. Dissolution and Solubility; 3.4.1. Dissolution Rate, Particle Size, and Solubility; 3.4.2. pH and Salts; 3.4.3. In Vivo Solubilization; 3.5. Solid State; References; 4 ADME; 4.1 Introduction; 4.2 Absorption; 4.2.1 Route of Administration; 4.2.2 Factors Determining Oral Bioavailability; 4.3 Distribution 4.3.1 Drug Distribution4.3.2 Volume of Distribution; 4.3.3 Free Drug Concentration; 4.3.4 CNS Penetration; 4.4 Elimination; 4.4.1 Elimination Versus Clearance; 4.4.2 Metabolism Versus Excretion; 4.4.3 Drug-Free Fraction and Clearance; 4.4.4 Lipophilicity and Clearance; 4.4.5 Transporters and Clearance; 4.4.6 Metabolism; 4.4.7 Excretion; 4.5 Drug Interactions; 4.5.1 Absorption-Driven DDI; 4.5.2 Distribution-Driven DDI; 4.5.3 Excretion-Driven DDI; 4.5.4 Metabolism-Driven DDI; 4.5.5 Tools for Studying Drug Metabolism; 4.5.6 Applications of Drug Metabolism Tools 4.5.7 Tools for Studying Drug Excretion |
| Record Nr. | UNINA-9910133588303321 |
|
Tsaioun Katya
|
||
| Hoboken, : Wiley, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
ADMET for Medicinal Chemists [[electronic resource] ] : A Practical Guide
| ADMET for Medicinal Chemists [[electronic resource] ] : A Practical Guide |
| Autore | Tsaioun Katya |
| Pubbl/distr/stampa | Hoboken, : Wiley, 2012 |
| Descrizione fisica | 1 online resource (524 p.) |
| Disciplina |
615.19
615/.19 |
| Altri autori (Persone) | KatesSteven A |
| Soggetto topico |
Drug Design
Drug Toxicity Drugs - Testing Drugs --Testing --Juvenile literature Pharmaceutical Preparations - chemistry Pharmacokinetics Metabolic Phenomena Drug Discovery Pharmacological Phenomena Natural Science Disciplines Kinetics Chemicals and Drugs Poisoning Biochemical Phenomena Chemistry, Pharmaceutical Substance-Related Disorders Disciplines and Occupations Investigative Techniques Physiological Phenomena Phenomena and Processes Chemical Phenomena Diseases Pharmacology Analytical, Diagnostic and Therapeutic Techniques and Equipment Biological Science Disciplines Chemistry Pharmaceutical Preparations Health & Biological Sciences Pharmacy, Therapeutics, & Pharmacology |
| ISBN |
1-280-59122-6
9786613621054 0-470-91509-9 0-470-91511-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
ADMET for Medicinal Chemists: A Practical Guide; CONTENTS; Preface; Contributors; 1 Introduction; 1.1 Introduction; 1.2 Voyage Through The Digestive System; 1.2.1 The Mouth; 1.2.2 The Stomach; 1.2.3 The Small Intestine: Duodenum; 1.2.4 The Small and Large Intestine: Jejunum, Ileum, Colon; 1.2.5 Hepatic-Portal Vein; 1.3 The Liver Metabolism; 1.3.1 CYP450 (CYPs); 1.4 The Kidneys; 1.4.1 Active Tubular Secretion; 1.4.2 Passive Tubular Reabsorption; 1.5 Conclusions; References; 2 In Silico ADME/Tox Predictions; 2.1 Introduction; 2.2 Key Computer Methods for ADME/Tox Predictions
2.2.1 Drug Discovery2.2.2 Applying or Not ADME/Tox Predictions, Divided Opinions; 2.2.3 In Silico ADME/Tox Methods and Modeling Approaches; 2.2.4 Physicochemistry, Pharmacokinetics, Drug-Like and Lead-Like Concepts; 2.2.5 Lipophilicity; 2.2.6 pKa; 2.2.7 Transport Proteins; 2.2.8 Plasma Protein Binding; 2.2.9 Metabolism; 2.2.10 Elimination; 2.2.11 Toxicity; 2.3 Preparation of Compound Collections and Computer Programs, Challenging ADME/Tox Predictions and Statistical Methods; 2.3.1 Preparation of Compound Collections and Computer Programs 2.3.2 Preparing a Compound Collection: Materials and Methods2.3.3 Cleaning and Designing the Compound Collection; 2.3.4 Searching for Similarity; 2.3.5 Generating 3D Structures; 2.4 ADME/Tox Predictions within Pharmaceutics Companies; 2.4.1 Actelion Pharmaceuticals Ltd.; 2.4.2 Bayer; 2.4.3 Bristol-Myers Squibb; 2.4.4 Hoffmann-La Roche Ltd.; 2.4.5 Neurogen Corporation; 2.4.6 Novartis; 2.4.7 Schering AG; 2.4.8 Vertex Pharmaceuticals; 2.5 Challenging ADME/Tox Predictions; 2.5.1 Tolcapone; 2.5.2 Factor V Inhibitors; 2.5.3 CRF-1 Receptor Antagonists; 2.6 Statistical Methods 2.6.1 Principal Component Analysis2.6.2 Partial Least Square; 2.6.3 Support Vector Machine; 2.6.4 Decision Trees; 2.6.5 Neural Networks; 2.7 Conclusions; References; 3 Absorption and Physicochemical Properties of the NCE; 3.1. Introduction; 3.2. Physicochemical Properties; 3.3. Stability; 3.4. Dissolution and Solubility; 3.4.1. Dissolution Rate, Particle Size, and Solubility; 3.4.2. pH and Salts; 3.4.3. In Vivo Solubilization; 3.5. Solid State; References; 4 ADME; 4.1 Introduction; 4.2 Absorption; 4.2.1 Route of Administration; 4.2.2 Factors Determining Oral Bioavailability; 4.3 Distribution 4.3.1 Drug Distribution4.3.2 Volume of Distribution; 4.3.3 Free Drug Concentration; 4.3.4 CNS Penetration; 4.4 Elimination; 4.4.1 Elimination Versus Clearance; 4.4.2 Metabolism Versus Excretion; 4.4.3 Drug-Free Fraction and Clearance; 4.4.4 Lipophilicity and Clearance; 4.4.5 Transporters and Clearance; 4.4.6 Metabolism; 4.4.7 Excretion; 4.5 Drug Interactions; 4.5.1 Absorption-Driven DDI; 4.5.2 Distribution-Driven DDI; 4.5.3 Excretion-Driven DDI; 4.5.4 Metabolism-Driven DDI; 4.5.5 Tools for Studying Drug Metabolism; 4.5.6 Applications of Drug Metabolism Tools 4.5.7 Tools for Studying Drug Excretion |
| Record Nr. | UNINA-9910830164603321 |
|
Tsaioun Katya
|
||
| Hoboken, : Wiley, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
ADMET for medicinal chemists : a practical guide / / edited by Katya Tsaioun, Steven A. Kates
| ADMET for medicinal chemists : a practical guide / / edited by Katya Tsaioun, Steven A. Kates |
| Pubbl/distr/stampa | Hoboken, N.J., : John Wiley & Sons, c2011 |
| Descrizione fisica | 1 online resource (524 p.) |
| Disciplina |
615.19
615/.19 |
| Altri autori (Persone) |
KatesSteven A. <1961->
TsaiounKatya |
| Soggetto topico |
Drugs - Testing
Drugs - Design |
| ISBN |
1-280-59122-6
9786613621054 0-470-91509-9 0-470-91511-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
ADMET for Medicinal Chemists: A Practical Guide; CONTENTS; Preface; Contributors; 1 Introduction; 1.1 Introduction; 1.2 Voyage Through The Digestive System; 1.2.1 The Mouth; 1.2.2 The Stomach; 1.2.3 The Small Intestine: Duodenum; 1.2.4 The Small and Large Intestine: Jejunum, Ileum, Colon; 1.2.5 Hepatic-Portal Vein; 1.3 The Liver Metabolism; 1.3.1 CYP450 (CYPs); 1.4 The Kidneys; 1.4.1 Active Tubular Secretion; 1.4.2 Passive Tubular Reabsorption; 1.5 Conclusions; References; 2 In Silico ADME/Tox Predictions; 2.1 Introduction; 2.2 Key Computer Methods for ADME/Tox Predictions
2.2.1 Drug Discovery2.2.2 Applying or Not ADME/Tox Predictions, Divided Opinions; 2.2.3 In Silico ADME/Tox Methods and Modeling Approaches; 2.2.4 Physicochemistry, Pharmacokinetics, Drug-Like and Lead-Like Concepts; 2.2.5 Lipophilicity; 2.2.6 pKa; 2.2.7 Transport Proteins; 2.2.8 Plasma Protein Binding; 2.2.9 Metabolism; 2.2.10 Elimination; 2.2.11 Toxicity; 2.3 Preparation of Compound Collections and Computer Programs, Challenging ADME/Tox Predictions and Statistical Methods; 2.3.1 Preparation of Compound Collections and Computer Programs 2.3.2 Preparing a Compound Collection: Materials and Methods2.3.3 Cleaning and Designing the Compound Collection; 2.3.4 Searching for Similarity; 2.3.5 Generating 3D Structures; 2.4 ADME/Tox Predictions within Pharmaceutics Companies; 2.4.1 Actelion Pharmaceuticals Ltd.; 2.4.2 Bayer; 2.4.3 Bristol-Myers Squibb; 2.4.4 Hoffmann-La Roche Ltd.; 2.4.5 Neurogen Corporation; 2.4.6 Novartis; 2.4.7 Schering AG; 2.4.8 Vertex Pharmaceuticals; 2.5 Challenging ADME/Tox Predictions; 2.5.1 Tolcapone; 2.5.2 Factor V Inhibitors; 2.5.3 CRF-1 Receptor Antagonists; 2.6 Statistical Methods 2.6.1 Principal Component Analysis2.6.2 Partial Least Square; 2.6.3 Support Vector Machine; 2.6.4 Decision Trees; 2.6.5 Neural Networks; 2.7 Conclusions; References; 3 Absorption and Physicochemical Properties of the NCE; 3.1. Introduction; 3.2. Physicochemical Properties; 3.3. Stability; 3.4. Dissolution and Solubility; 3.4.1. Dissolution Rate, Particle Size, and Solubility; 3.4.2. pH and Salts; 3.4.3. In Vivo Solubilization; 3.5. Solid State; References; 4 ADME; 4.1 Introduction; 4.2 Absorption; 4.2.1 Route of Administration; 4.2.2 Factors Determining Oral Bioavailability; 4.3 Distribution 4.3.1 Drug Distribution4.3.2 Volume of Distribution; 4.3.3 Free Drug Concentration; 4.3.4 CNS Penetration; 4.4 Elimination; 4.4.1 Elimination Versus Clearance; 4.4.2 Metabolism Versus Excretion; 4.4.3 Drug-Free Fraction and Clearance; 4.4.4 Lipophilicity and Clearance; 4.4.5 Transporters and Clearance; 4.4.6 Metabolism; 4.4.7 Excretion; 4.5 Drug Interactions; 4.5.1 Absorption-Driven DDI; 4.5.2 Distribution-Driven DDI; 4.5.3 Excretion-Driven DDI; 4.5.4 Metabolism-Driven DDI; 4.5.5 Tools for Studying Drug Metabolism; 4.5.6 Applications of Drug Metabolism Tools 4.5.7 Tools for Studying Drug Excretion |
| Altri titoli varianti | Absorption, distribution, metabolism, excretion, toxicity for medical chemists |
| Record Nr. | UNINA-9910876861103321 |
| Hoboken, N.J., : John Wiley & Sons, c2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Admixtures in crystallization / / Jaroslav Nyvlt, Joachim Ulrich
| Admixtures in crystallization / / Jaroslav Nyvlt, Joachim Ulrich |
| Autore | Nyvlt Jaroslav |
| Pubbl/distr/stampa | Weinheim ; ; New York, : VCH, c1995 |
| Descrizione fisica | 1 online resource (397 p.) |
| Disciplina |
615.19
660.284298 |
| Altri autori (Persone) | UlrichJoachim |
| Soggetto topico |
Crystallization - Industrial applications
Crystals - Additives |
| ISBN |
1-281-75861-2
9786611758615 3-527-61531-8 3-527-61530-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Admixtures in Crystallization; Contents; 1. Introduction; 2. Classification of Admixtures; 3. Influence of Admixtures on Nucleation; 3.1. Homogeneous Nucleation; 3.2. Heterogeneous Nucleation; 3.3. Secondary Nucleation; 4. Influence of Admixtures on Crystal Growth; 4.1. The Role of the Solid Surface; 4.2. The Role of the Interphase Solid - Liquid; 5. Influence of Admixtures on Crystal Shape; 6. Influence of Solvents; 7. Distribution of Admixtures; 7.1. Solid Solutions; 7.2. Isomorphous Inclusion; 7.3. Anomalous Mixed Crystals; 7.4. Adsorption Inclusion; 7.5. Mechanism of Internal Adsorption
7.6. Mechanical Inclusions7.7. Materials Balance for Crystallization in Presence of Impurities; 7.8. Cascade Purification; 8 . Notations; 9 . References; 10 . Tables; Formula Index; 11 . References to Tables; 12 . Subject Index |
| Record Nr. | UNINA-9910876644103321 |
|
Nyvlt Jaroslav
|
||
| Weinheim ; ; New York, : VCH, c1995 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Admixtures in crystallization [[electronic resource] /] / Jaroslav Nývlt, Joachim Ulrich
| Admixtures in crystallization [[electronic resource] /] / Jaroslav Nývlt, Joachim Ulrich |
| Autore | Nývlt Jaroslav |
| Pubbl/distr/stampa | Weinheim ; ; New York, : VCH, c1995 |
| Descrizione fisica | 1 online resource (397 p.) |
| Disciplina |
615.19
660.284298 |
| Altri autori (Persone) | UlrichJoachim |
| Soggetto topico |
Crystallization - Industrial applications
Crystals - Additives |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-281-75861-2
9786611758615 3-527-61531-8 3-527-61530-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Admixtures in Crystallization; Contents; 1. Introduction; 2. Classification of Admixtures; 3. Influence of Admixtures on Nucleation; 3.1. Homogeneous Nucleation; 3.2. Heterogeneous Nucleation; 3.3. Secondary Nucleation; 4. Influence of Admixtures on Crystal Growth; 4.1. The Role of the Solid Surface; 4.2. The Role of the Interphase Solid - Liquid; 5. Influence of Admixtures on Crystal Shape; 6. Influence of Solvents; 7. Distribution of Admixtures; 7.1. Solid Solutions; 7.2. Isomorphous Inclusion; 7.3. Anomalous Mixed Crystals; 7.4. Adsorption Inclusion; 7.5. Mechanism of Internal Adsorption
7.6. Mechanical Inclusions7.7. Materials Balance for Crystallization in Presence of Impurities; 7.8. Cascade Purification; 8 . Notations; 9 . References; 10 . Tables; Formula Index; 11 . References to Tables; 12 . Subject Index |
| Record Nr. | UNINA-9910144330103321 |
|
Nývlt Jaroslav
|
||
| Weinheim ; ; New York, : VCH, c1995 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Admixtures in crystallization [[electronic resource] /] / Jaroslav Nývlt, Joachim Ulrich
| Admixtures in crystallization [[electronic resource] /] / Jaroslav Nývlt, Joachim Ulrich |
| Autore | Nývlt Jaroslav |
| Pubbl/distr/stampa | Weinheim ; ; New York, : VCH, c1995 |
| Descrizione fisica | 1 online resource (397 p.) |
| Disciplina |
615.19
660.284298 |
| Altri autori (Persone) | UlrichJoachim |
| Soggetto topico |
Crystallization - Industrial applications
Crystals - Additives |
| ISBN |
1-281-75861-2
9786611758615 3-527-61531-8 3-527-61530-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Admixtures in Crystallization; Contents; 1. Introduction; 2. Classification of Admixtures; 3. Influence of Admixtures on Nucleation; 3.1. Homogeneous Nucleation; 3.2. Heterogeneous Nucleation; 3.3. Secondary Nucleation; 4. Influence of Admixtures on Crystal Growth; 4.1. The Role of the Solid Surface; 4.2. The Role of the Interphase Solid - Liquid; 5. Influence of Admixtures on Crystal Shape; 6. Influence of Solvents; 7. Distribution of Admixtures; 7.1. Solid Solutions; 7.2. Isomorphous Inclusion; 7.3. Anomalous Mixed Crystals; 7.4. Adsorption Inclusion; 7.5. Mechanism of Internal Adsorption
7.6. Mechanical Inclusions7.7. Materials Balance for Crystallization in Presence of Impurities; 7.8. Cascade Purification; 8 . Notations; 9 . References; 10 . Tables; Formula Index; 11 . References to Tables; 12 . Subject Index |
| Record Nr. | UNISA-996212583803316 |
|
Nývlt Jaroslav
|
||
| Weinheim ; ; New York, : VCH, c1995 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Admixtures in crystallization [[electronic resource] /] / Jaroslav Nývlt, Joachim Ulrich
| Admixtures in crystallization [[electronic resource] /] / Jaroslav Nývlt, Joachim Ulrich |
| Autore | Nývlt Jaroslav |
| Pubbl/distr/stampa | Weinheim ; ; New York, : VCH, c1995 |
| Descrizione fisica | 1 online resource (397 p.) |
| Disciplina |
615.19
660.284298 |
| Altri autori (Persone) | UlrichJoachim |
| Soggetto topico |
Crystallization - Industrial applications
Crystals - Additives |
| ISBN |
1-281-75861-2
9786611758615 3-527-61531-8 3-527-61530-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Admixtures in Crystallization; Contents; 1. Introduction; 2. Classification of Admixtures; 3. Influence of Admixtures on Nucleation; 3.1. Homogeneous Nucleation; 3.2. Heterogeneous Nucleation; 3.3. Secondary Nucleation; 4. Influence of Admixtures on Crystal Growth; 4.1. The Role of the Solid Surface; 4.2. The Role of the Interphase Solid - Liquid; 5. Influence of Admixtures on Crystal Shape; 6. Influence of Solvents; 7. Distribution of Admixtures; 7.1. Solid Solutions; 7.2. Isomorphous Inclusion; 7.3. Anomalous Mixed Crystals; 7.4. Adsorption Inclusion; 7.5. Mechanism of Internal Adsorption
7.6. Mechanical Inclusions7.7. Materials Balance for Crystallization in Presence of Impurities; 7.8. Cascade Purification; 8 . Notations; 9 . References; 10 . Tables; Formula Index; 11 . References to Tables; 12 . Subject Index |
| Record Nr. | UNINA-9910830084303321 |
|
Nývlt Jaroslav
|
||
| Weinheim ; ; New York, : VCH, c1995 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advanced drug delivery reviews
| Advanced drug delivery reviews |
| Pubbl/distr/stampa | Amsterdam : Elsevier Science |
| Descrizione fisica | v. : ill. |
| Disciplina | 615.19 |
| Soggetto topico | Farmacologia - Periodici |
| ISSN | 0169-409X |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Note periodicità | Pubbl. 7 voll. di 3 fasc. l'anno |
| Record Nr. | UNISA-990001073470203316 |
| Amsterdam : Elsevier Science | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Advanced practical medicinal chemistry [[electronic resource] ] : theory, methodology, purification, usages / / Ashutoch Kar
| Advanced practical medicinal chemistry [[electronic resource] ] : theory, methodology, purification, usages / / Ashutoch Kar |
| Autore | Kar Ashutosh |
| Pubbl/distr/stampa | New Delhi, : New Age International (P) Ltd., Publishers, 2004 |
| Descrizione fisica | 1 online resource (332 p.) |
| Disciplina | 615.19 |
| Soggetto topico | Pharmaceutical chemistry |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-282-07402-4
9786612074028 81-224-2553-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Cover; Preface; Contents; Chapter 1. Safety in a Chemistry Laboratory; Chapter 2. Drug Synthesis; Chapter 3.Performing the Reactions; Chapter 4. Synthesis of Medicinal Compounds; Index |
| Record Nr. | UNINA-9910454405803321 |
|
Kar Ashutosh
|
||
| New Delhi, : New Age International (P) Ltd., Publishers, 2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
